Fatty liver symptoms: what each stage looks like and why it matters

Fatty liver disease affects roughly 25–30% of Taiwanese adults, yet most people have no idea they have it. The liver accumulates fat quietly for years before symptoms appear. By the time warning signs become obvious, significant damage may already be done. Understanding what each stage looks like — and what drives the progression — gives you a meaningful head start.

Three stages of fatty liver: why most people miss the early signs

Non-alcoholic fatty liver disease (NAFLD) progresses through three distinct stages, each with a different symptom profile:

Stage 1 — Simple steatosis: Fat accumulates in liver cells (more than 5% by weight), but the liver still functions normally. There are virtually no symptoms. Most people discover it through an abdominal ultrasound or elevated liver enzymes on a routine blood panel.

Stage 2 — Non-alcoholic steatohepatitis (NASH): About 20% of simple steatosis cases progress here within a few years. Fat triggers chronic inflammation, and liver cells begin to sustain damage. Fatigue, mild right-side abdominal discomfort, and reduced appetite may appear — but these are easy to dismiss as stress or poor sleep.

Stage 3 — Fibrosis and cirrhosis risk: Repeated inflammation causes fibrous tissue to replace healthy liver cells. When cirrhosis develops, symptoms become unmistakable: jaundice, abdominal fluid accumulation, easy bruising, and swollen legs. At this point, much of the damage is irreversible.

Early fatty liver symptoms: 4 signals that often go unnoticed

Stage 1 is largely silent, but a few signals can hint at trouble:

1. Persistent fatigue despite adequate rest — the liver is the body’s primary metabolic hub. Fat accumulation reduces its efficiency, leaving you chronically drained.
2. Dull pressure or fullness under the right ribcage — mild liver enlargement can cause a subtle aching sensation, especially after meals. Many people attribute this to digestion issues.
3. Triglycerides above 150 mg/dL or fasting blood sugar above 100 mg/dL — both are closely linked to liver fat accumulation. Recurring abnormal values on health checks are a reliable early signal.
4. Growing waist circumference — liver fat and visceral fat accumulate together. Waist measurements above 90 cm for men or 80 cm for women indicate elevated metabolic risk.

These observations require medical evaluation to confirm. This article is for educational purposes only — consult your physician if you have concerns.

Advanced stage symptoms: when fatty liver becomes hard to ignore

As NAFLD progresses to NASH and beyond, symptoms become more pronounced:

• Noticeable loss of appetite and unexplained weight loss
• Yellowing of the skin or whites of the eyes (jaundice) — requires immediate medical attention
• Abdominal swelling from fluid buildup (ascites)
• Easy bruising and slow wound healing due to reduced clotting factor production
• Spider angiomas or redness on the palms — signs of impaired estrogen metabolism

A long-term study published in Hepatology found that NAFLD patients with concurrent metabolic syndrome had more than a 40% chance of progressing to NASH within 10 years. Addressing the metabolic environment early produces far better outcomes than waiting for symptoms to worsen.

How CNFCD approaches the metabolic root of fatty liver

Fatty liver is primarily driven by insulin resistance, not simply by eating too much fat. When blood sugar regulation breaks down, the liver compensates by converting excess glucose into triglycerides through a process called de novo lipogenesis — and those triglycerides accumulate in liver cells. Lowering liver enzyme numbers without addressing this underlying mechanism leaves the root cause untouched.

CNFCD is a science-based dietary coaching method developed by Weikang. Hsien-Hung Shih (ResetWith) provides individualized dietary consultations using CNFCD. The dietary adjustments focus on three areas:

• Stabilizing post-meal blood sugar spikes to reduce sustained insulin stimulation
• Restructuring food choices to minimize hepatic triglyceride synthesis
• Supporting the gut environment to reduce chronic inflammatory signals that burden the liver

Multiple randomized controlled trials — including Romero-Gómez et al. in Lancet Gastroenterology & Hepatology (2017) — confirm that dietary structure interventions have meaningful impact on NAFLD outcomes, independent of calorie counting.

CNFCD provides dietary and lifestyle guidance only. It does not replace medical diagnosis or treatment. Please consult your physician if you have health concerns.
👉 Ready to address your metabolic health through diet? Feel free to reach out for an initial consultation.
— Hsien-Hung Shih | ResetWith Health Coach | cnfcd.life

Frequently asked questions

Q: Does fatty liver always cause symptoms?

Stage 1 fatty liver causes virtually no symptoms. Most people discover it by accident during a routine checkup. Mild fatigue or right-side abdominal discomfort may be present, but these are easily overlooked. Noticeable symptoms typically appear only in Stage 2 or beyond.

Q: My ultrasound shows fatty liver — do I need medication?

No drug is currently approved specifically for NAFLD. International liver disease guidelines (EASL, AASLD) consistently recommend lifestyle intervention — particularly dietary adjustment and weight management — as the first-line approach. Whether medication is needed depends on your specific clinical picture; your physician is the right person to assess that.

Q: Can fatty liver be reversed?

Stage 1 fatty liver has strong reversibility with dietary and lifestyle changes. Stage 2 NASH can be slowed or stabilized with active intervention. Stage 3 fibrosis is harder to reverse once established — which is why early action matters significantly more than late-stage management.

Q: Can I follow CNFCD alongside another diet plan?

CNFCD is designed to be followed independently. It is not recommended to combine it with other dietary approaches or drug-based interventions at the same time.

---

Recommended next reads

• What is CNFCD?
• CNFCD complete guide
• Knowledge hub
• Insulin resistance guide
• Women and metabolic fat loss
• Plans and pricing

Author, Review, and Health Content Note

Publisher: ResetWith consulting team. Principal consultant: Pangpang / Sean Shih. Last updated: 2026-05-30.

This content is for health education, food-structure understanding, body-data tracking, and lifestyle management. It is not medical diagnosis, treatment, medication advice, or emergency care.

Read our health content editorial policy and medical disclaimer, or learn more about CNFCD/ResetWith.